Stimulant withdrawal including amphetamines, methamphetamine or methcathinone

Description

Stimulant withdrawal including amphetamines, methamphetamine and methcathinone is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of stimulants in individuals who have developed Stimulant dependence or have used stimulants for a prolonged period or in large amounts. Stimulant withdrawal can also occur when prescribed stimulants have been used in standard therapeutic doses. Presenting features of stimulant withdrawal may include dysphoric mood, irritability, fatigue, insomnia or (more commonly) hypersomnia, vivid and unpleasant dreams, increased appetite, psychomotor agitation or retardation, and craving for amphetamine or related stimulants.

Index terms

Stimulant withdrawal including amphetamines, methamphetamine or methcathinone

Excludes

6C45.4 – Cocaine withdrawal
6C47.4 – Synthetic cathinone withdrawal
6C48.3 – Caffeine withdrawal

Exclusions from above levels

6C45 – Disorders due to use of cocaine
6C47 – Disorders due to use of synthetic cathinones
6C48 – Disorders due to use of caffeine

Show allHide

QE11.4 – Hazardous use of stimulants including amphetamines or methamphetamine
QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Sibling codes

6C46.0 – Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
6C46.1 – Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone
6C46.2 – Stimulant dependence including amphetamines, methamphetamine or methcathinone
6C46.3 – Stimulant intoxication including amphetamines, methamphetamine or methcathinone
6C46.5 – Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
6C46.6 – Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone
6C46.7 – Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone
6C46.Y – Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
6C46.Z – Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified

Foundation entity

Stimulant withdrawal including amphetamines, methamphetamine or methcathinone – http://id.who.int/icd/entity/494523519

Allowed postcoordination axes

Part of: 6C46: Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone › 06: Mental, behavioural or neurodevelopmental disorders